MAGID FAHIM

Magid Fahim is a Senior Lecturer in the Faculty of Medicine at the University of Queensland and Consultant Nephrologist at Princess Alexandra Hospital. He earned his MBChB with Distinction from the University of Otago, a PhD from the University of Queensland, and is a Fellow of the Royal Australasian College of Physicians (FRACP). Fahim has held his academic appointment at the University of Queensland since at least 2007 and serves as a clinical trialist with the Australasian Kidney Trials Network.

His research specializes in cardiovascular disease in chronic kidney disease patients, including diagnostic, monitoring, and treatment advancements. Key areas include perioperative outcomes and risk in dialysis patients undergoing surgery, peritonitis in peritoneal dialysis, kidney transplant fluid management, and cardiac biomarker variation in dialysis. Prominent publications are "Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases" (American Journal of Kidney Diseases, 2010, 155 citations), "Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases" (Nephrology Dialysis Transplantation, 2010, 81 citations), "Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial" (The Lancet, 2023, 80 citations), "Cardiac testing for coronary artery disease in potential kidney transplant recipients" (Cochrane Database of Systematic Reviews, 2011, 163 citations), and contributions to New England Journal of Medicine articles on coronary disease management and allopurinol effects in advanced kidney disease (2020). With over 900 citations across 60+ publications, his work influences nephrology practice. Fahim received the Translational Research Institute Development Award and was part of the Digital Metro North team awarded the Queensland Premier’s Award for Excellence for COVID-19 digital innovations in 2021. He has presented at Renal Society of Australasia events.